| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fraser A M Scott, Matt Butler, Jonathan P Roger. The limited clinical utility of a routine creatine kinase (CK) on admission to a psychiatric inpatient unit. BMC psychiatry. vol 24. issue 1. 2024-12-19. PMID:39696215. |
ck can be used as an investigation to support the diagnosis of conditions such as neuroleptic malignant syndrome (nms), a rare idiosyncratic drug reaction - classically to antipsychotic medications - which can be fatal. |
2024-12-19 |
2024-12-21 |
Not clear |
| Gloria Akuamoah-Boateng, Kayla A Buttafuoco, Courtney C Sutton, Brian P Hacket. Neuroleptic Malignant Syndrome in a 10-Month-Old Ex-Preterm Infant with Delirium. AJP reports. vol 14. issue 4. 2024-11-14. PMID:39534408. |
neuroleptic malignant syndrome (nms) is a rare adverse drug reaction associated with exposure to antipsychotics and other antidopaminergic medications. |
2024-11-14 |
2024-11-17 |
Not clear |
| Antonio Funcis, Beatrice Ravera, Paola Zinzi, Marcella Solito, Martina Petracca, Paolo Calabresi, Anna Rita Bentivogli. Neuroleptic malignant syndrome in Huntington disease. European journal of neurology. 2024-10-24. PMID:39444167. |
despite the wide use of dopamine receptor blocking agents (drbas) in huntington disease (hd), neuroleptic malignant syndrome (nms) is rarely described in this population. |
2024-10-24 |
2024-10-26 |
Not clear |
| Yin Ye Lai, Normaizuwana Mohamed Mokhtar, Intan Nureslyna Samsudin, Subashini C Thambia. Acute kidney injury induced lithium toxicity with concomitant neuroleptic malignant syndrome. BioMedicine. vol 14. issue 3. 2024-10-10. PMID:39386183. |
neuroleptic malignant syndrome (nms) is a rare but potentially fatal complication due to central dopaminergic blockade. |
2024-10-10 |
2024-10-12 |
Not clear |
| Byungchul Yu, Ji Yeon Lee, Yong Beom Kim, Hee Yeon Park, Junsu Jung, Youn Yi J. Management of a trauma patient with alcohol withdrawal who developed neuroleptic malignant syndrome in Korea: a case report. Journal of trauma and injury. vol 36. issue 3. 2024-10-09. PMID:39381710. |
neuroleptic malignant syndrome (nms) is a rare but fatal condition, with a high mortality rate. |
2024-10-09 |
2024-10-11 |
Not clear |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
introduction in neuropsychiatric pharmacotherapy, neuroleptic malignant syndrome (nms) is a potentially serious side effect of antipsychotics characterized primarily by fever, disorientation, extrapyramidal disorders, and autonomic nervous system imbalance, which can lead to death if left untreated. |
2024-10-01 |
2024-10-03 |
Not clear |
| Nikhil Vojjala, Srikant Kashinath Malegaonkar, Kajal Arora, Inderpaul Singh Sehgal, Ashok Kumar Pann. Dual Toxidrome of Anti-cholinergic Storm and Neuroleptic Malignant Syndrome: A Therapeutic Challenge Overcome by Intrathecal Neostigmine. The Neurohospitalist. vol 14. issue 4. 2024-09-24. PMID:39308477. |
anticholinergic toxicity and neuroleptic malignant syndrome (nms) are common toxidromes in medical emergencies. |
2024-09-24 |
2024-09-26 |
Not clear |
| Hayri Can Özden, Şeref Can Güre. Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. 2024-09-19. PMID:39297275. |
neuroleptic malignant syndrome (nms) is an idiosyncratic and potentially life-threatening drug reaction. |
2024-09-19 |
2024-09-21 |
Not clear |
| Tarun Kutumbaka, Sivaprakash Varadan, R B Sudagar Sing. The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity. Cureus. vol 16. issue 7. 2024-08-05. PMID:39099918. |
neuroleptic malignant syndrome (nms) is a rare life-threatening condition associated with the use of antipsychotic medications. |
2024-08-05 |
2024-08-07 |
Not clear |
| John Allonce, Sikandar Khan, Brian Pulfor. Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report. Journal of investigative medicine high impact case reports. vol 12. 2024-07-24. PMID:39044558. |
neuroleptic malignant syndrome (nms) is a severe adverse reaction associated with neuroleptic or antipsychotic drugs. |
2024-07-24 |
2024-07-26 |
Not clear |
| Nikita H Seth, Raghumahanti Raghuveer, Moh'd Irshad Quresh. Integrating Physiotherapy in Neuroleptic Malignant Syndrome Management: A Case Report. Cureus. vol 16. issue 6. 2024-07-23. PMID:39040743. |
neuroleptic malignant syndrome (nms) is a rare but potentially fatal condition characterized by hyperthermia, autonomic dysregulation, altered mental status, and muscular rigidity. |
2024-07-23 |
2024-07-25 |
Not clear |
| Shunsuke Nakamura, Atsuyoshi Iida, Kohei Tsukahara, Hiromichi Nait. Successful Diagnosis of Neuroleptic Malignant Syndrome in an Unconscious Patient Using Amplitude-Integrated Electroencephalography: A Case Report. Cureus. vol 16. issue 6. 2024-07-10. PMID:38978900. |
neuroleptic malignant syndrome (nms) is a rare but life-threatening medical condition often characterized by altered consciousness and clinical features resembling seizures. |
2024-07-10 |
2024-07-12 |
Not clear |
| Hitomi Komoriya, Konoka Nomura, Toshinori Shirata, Tadahiro Kobayashi, Masaki Nakane, Keisuke Noto, Ryota Kobayashi, Akihito Suzuk. A fatal case of fulminant neuroleptic malignant syndrome: A case report. PCN reports : psychiatry and clinical neurosciences. vol 2. issue 1. 2024-06-13. PMID:38868402. |
neuroleptic malignant syndrome (nms), a rare but potentially life-threatening adverse reaction to treatment with antipsychotic drugs, is characterized by hyperthermia, muscle rigidity, impaired consciousness, and autonomic disturbances. |
2024-06-13 |
2024-06-15 |
Not clear |
| Seyedehnasibeh Sadati, Forouzan Elyasi, Zahra Shyasi, Behzad Rouhanizade. Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report. Neuropsychopharmacology reports. 2024-06-04. PMID:38832410. |
neuroleptic malignant syndrome (nms) is a rare and potentially life-threatening condition that may arise at any point during treatment and is often associated with adverse reactions to dopamine-blocking agents. |
2024-06-04 |
2024-06-06 |
Not clear |
| Sacha Celik, Veronica de Gennaro, João C-P-Silva, Kevin Swierkosz-Lenart, Armin von Gunte. Successful Treatment of Both Refractory Neuroleptic Malignant Syndrome and Subsequent Catatonia With Electroconvulsive Therapy in a Patient With Suspected Kufs Disease. The journal of ECT. 2024-06-03. PMID:38830195. |
we describe a patient suffering from probable kufs disease who developed a neuroleptic malignant syndrome (nms) after use of an antipsychotic agent over some weeks during hospitalization due to neuropsychiatric symptoms. |
2024-06-03 |
2024-06-06 |
Not clear |
| Waleed M Sweile. Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis. Orphanet journal of rare diseases. vol 19. issue 1. 2024-06-02. PMID:38825678. |
this study aimed to analyze and map scientific literature on neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) from prestigious, internationally indexed journals. |
2024-06-02 |
2024-06-05 |
Not clear |
| Jordan P Fader, Madison Walker Evans, Austin M Lundgren, Trenton B Sigmund, Taylor J Alle. Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report. Cureus. vol 16. issue 3. 2024-05-01. PMID:38686249. |
neuroleptic malignant syndrome (nms) is a severe reaction to antipsychotic medications characterized by fever, muscle rigidity, altered mental status, and autonomic dysfunction. |
2024-05-01 |
2024-05-03 |
Not clear |
| Eduardo Macedo, Filipa Rodrigues, Ana Rita Marques, Luís Ribeiro, Pedro Silveir. Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels. Cureus. vol 16. issue 3. 2024-04-17. PMID:38628997. |
neuroleptic malignant syndrome (nms) is a rare, life-threatening neurologic emergency known to be related to the administration or sudden withdrawal of dopaminergic medications. |
2024-04-17 |
2024-04-19 |
Not clear |
| Zong-Jun Te. A rare case of prochlorperazine-induced neuroleptic malignant syndrome. The American journal of emergency medicine. 2024-04-04. PMID:38575461. |
neuroleptic malignant syndrome (nms) is a rare yet severe condition typically associated with antipsychotic medications. |
2024-04-04 |
2024-04-07 |
Not clear |
| Nicole Kraaijvanger, Tim Mielo. Neuroleptic malignant syndrome after overdose of haloperidol - A case report. Toxicology reports. vol 12. 2024-04-01. PMID:38560509. |
the neuroleptic malignant syndrome (nms), alternatively referred to as the antipsychotic malignant syndrome, is a potentially fatal condition that is infrequently observed and is linked to the administration of antipsychotic medications. |
2024-04-01 |
2024-04-04 |
Not clear |